Treatment of infections caused by rapidly growing mycobacteria in the era of the newer macrolides.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Research in Microbiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0923-2508(96)80200-2PMID 8761719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of in vitro susceptibility of mycobacteria to ansamycin.

  2015cited by this paper
• Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov.

  1995cited by this paper
• Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.

  1995cited by this paper
• Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin.

  1995cited by this paper
• Tetracycline resistance determinants in Mycobacterium and Streptomyces species

  1994cited by this paper
• Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.

  1994cited by this paper
• Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity?

  1994cited by this paper
• Clinical Trial of Clarithromycin for Cutaneous (Disseminated) Infection due to Mycobacterium chelonae

  1993cited by this paper
• Clinical features of disease caused by rapidly growing mycobacteria

  1993cited by this paper
• Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism

  1993cited by this paper
• Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.

  1993cited by this paper
• Soft-tissue infection due to Mycobacterium smegmatis: report of two cases.

  1993cited by this paper
• Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum

  1993cited by this paper
• Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

  1992cited by this paper
• Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

  1992cited by this paper
• Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid

  1991cited by this paper
• Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.

  1991cited by this paper
• The surgical management of atypical mycobacterial soft-tissue infections.

  1990cited by this paper
• Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

  1990cited by this paper
• Human disease due to Mycobacterium smegmatis.

  1988cited by this paper
• In vitro susceptibility ofMycobacterium tuberculosis,Mycobacterium fortuitum andMycobacterium chelonei to augmentin

  1986cited by this paper
• In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria

  1986cited by this paper
• Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

  1985cited by this paper
• Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

  1985cited by this paper
• Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.

  1985cited by this paper
• Spectrum of disease due to rapidly growing mycobacteria.

  1983cited by this paper
• Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis.

  1982cited by this paper
• Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

  1982cited by this paper
• In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins

  1982cited by this paper
• Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.

  1981cited by this paper
• Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.

  1981cited by this paper
• Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex.

  1981cited by this paper
• Identification of clinically significant Mycobacterium fortuitum complex isolates

  1981cited by this paper
• Antimicrobial Susceptibility Testing of Mycobacterium fortuitum Complex

  1979cited by this paper
• In Vitro Susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to Amikacin

  1978cited by this paper

• Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection.

  2023cites this paper
• Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria.

  2009cites this paper
• Structure-activity relationships of macrolides against Mycobacterium tuberculosis.

  2008cites this paper
• Clinical Manifestations of Pulmonary Infection Due to Rapidly Growing Nontuberculous Mycobacteria

  2003cites this paper
• Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria

  2002cites this paper
• Nontuberculous mycobacterial infections of the lung

  2000cites this paper
• Mycobacterial dermatitis.

  1999cites this paper
• Rapidly growing mycobacterial lung infection in association with esophageal disorders.

  1999cites this paper
• Molecular Cloning and Functional Analysis of a Novel Tetracycline Resistance Determinant, tet(V), fromMycobacterium smegmatis

  1998cites this paper